Mepolizumab Trial for EGPA/CSS Patients Now Enrolling

The purpose of this randomized, double-blind study is to investigate the efficacy and safety of mepolizumab (300 milligram mg administered subcutaneously every four weeks) compared with a placebo over a more »


Read More

PROMIS – Quality of Life Survey

 Vivek Nagaraja, MD and Dinesh Khanna, MD, MSc at the University of Michigan Health System, are conducting a piece of research called PROMIS (Patient Reported Outcomes Measurement Information System) in more »


Read More

VCRC Genetic Repository One-Time DNA Study

The Vasculitis Clinical Research Consortium is pleased to let you know the University of Michigan, Ann Arbor is now enrolling patients for our study: VCRC Genetic Repository One-Time DNA Study more »


Read More

AAV Patients and Volunteers needed for a Clinical Trial in Vasculitis

Patients with anti-neutrophil cytoplasm antibody (ANCA)-associated Vasculitis (AAV) are at risk of disease relapse and so are often kept on long-term medication that suppresses their immune system. These medications may more »


Read More

New VCRC Trial Enrolling Patients Now! The Assessment of Prednisone in Remission (TAPIR) Trial

This is a trial for patients with granulomatosis with polyangiitis (Wegener’s). You are invited to participate in a clinical trial being conducted by the Vasculitis Clinical Research Consortium (VCRC) under more »


Read More